Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Sangamo Therapeutics: Q4 Earnings Insights

Sangamo Therapeutics (NASDAQ:SGMO) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Sangamo Therapeutics beat estimated earnings by 23.53%, reporting an EPS of $-0.26 versus an estimate of $-0.34.

Revenue was up $2.19 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 0.73% increase in the share price the next day.

Here's a look at Sangamo Therapeutics's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.34 -0.31 -0.30 -0.21
EPS Actual -0.33 -0.33 -0.32 -0.29
Revenue Estimate 25.19M 26.48M 23.98M 32.15M
Revenue Actual 28.56M 27.87M 26.28M 25.80M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.